col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


16 Ergebisse       Seite 1

 [1] 
Elsevier: SLAS DISCOVERY
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Aug―12 High Throughput Screening for SARS-CoV-2 Inhibitors Targeting 5 Helix Bundle Emery Smith, Qibin Geng, Justin Shumate, Yuka Otsuka, Louis Scampavia, Thomas D. Bannister, Timothy P. Spicer
2 [GO] 2025―Apr―09 SLAS special issue editorial 2025: Outcomes From Antiviral Drug Discovery for Pathogens of Pandemic Concern Timothy P. Spicer, Louis D. Scampavia
3 [GO] 2025―Feb―01 Comparative evaluation of cell-based assay technologies for scoring drug-induced condensation of SARS-CoV-2 nucleocapsid protein Rui Tong Quek, Cyna R. Shirazinejad, Christina L. Young, Kierra S. Hardy, Samuel Lim, Phillip J. Elms, et al. (+3)
4 [GO] 2024―Nov―04 Rapid-response RNA-fluorescence in situ hybridization (FISH) assay platform for coronavirus antiviral high-throughput screening Ryan Chan, Christian Shema Mugisha, Vorada Chuenchob, Stephanie A. Moquin, Ujjini H. Manjunatha, Nadine Jarrousse, et al. (+4)
5 [GO] 2024―Aug―23 High throughput screening for SARS-CoV-2 helicase inhibitors Yuka Otsuka, Eunjung Kim, Austin Krueger, Justin Shumate, Chao Wang, Bilel Bdiri, et al. (+6)
6 [GO] 2024―Aug―23 SARS-CoV-2 Mpro inhibitor identification using a cellular gain-of-signal assay for high-throughput screening Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, Yuka Otsuka, Justin Shumate, Ashley Cuell, et al. (+13)
7 [GO] 2024―Aug―17 Simultaneous Screening for Selective SARS-CoV-2, Lassa, and Machupo Virus Entry Inhibitors Yuka Otsuka, Lizhou Zhang, Huihui Mou, Justin Shumate, Claire E. Kitzmiller, Louis Scampavia, et al. (+4)
8 [GO] 2024―Aug―14 Development of a Sensitive High-throughput Enzymatic Assay Capable of Measuring Sub-nanomolar Inhibitors of SARS-CoV2 Mpro Peter Kovar, Paul L Richardson, Alla Korepanova, Gustavo A Afanador, Vladimir Stojkovic, Tao Li, et al. (+5)
9 [GO] 2024―Mai―16 A High-throughput Response to the SARS-CoV-2 Pandemic Lynn Rasmussen, Shalisa Sanders, Melinda Sosa, Sara McKellip, N. Miranda Nebane, Yohanka Martinez-Gzegozewska, et al. (+9)
10 [GO] 2024―Feb―01 Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays Nicole L. Inniss, Margarita Rzhetskaya, Ted Ling-Hu, Ramon Lorenzo-Redondo, Kelly E. Bachta, Karla J.F. Satchell, Judd F. Hultquist
11 [GO] 2023―Jul―18 Role Of Vaccines Against COVID-19 Pandemic Professor Dr. Batool Mutar Mahdi, Dr. Mustafa Almukhtar
12 [GO] 2023―Jan―14 High Throughput Screening for Drugs that Inhibit 3C-Like Protease in SARS-CoV-2 Emery Smith, Meredith E. Davis-Gardner, Ruben D. Garcia-Ordonez, Tu-Trinh Nguyen, Mitchell Hull, Emily Chen, et al. (+7)
13 [GO] 2022―Jun―04 Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens Serena Nihal, Kristyan Guppy-Coles, Mahnaz D. Gholami, Chamindie Punyadeera, Emad L. Izake
14 [GO] 2022―Jan―25 Identification of potent small molecule inhibitors of SARS-CoV-2 entry Sonia Mediouni, Huihui Mou, Yuka Otsuka, Joseph Anthony Jablonski, Robert Scott Adcock, Lalit Batra, et al. (+18)
15 [GO] 2022―Jan―25 Discovery of SARS-CoV-2 main protease covalent inhibitors from a DNA-encoded library selection Rui Ge, Zuyuan Shen, Jian Yin, Wenhua Chen, Qi Zhang, Yulong An, et al. (+4)
16 [GO] 2022―Jan―25 A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry Miao Xu, Manisha Pradhan, Kirill Gorshkov, Jennifer D. Petersen, Min Shen, Hui Guo, et al. (+10)
 [1] 

16 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.003 sec